Crispr Therapeutics shares tumble after significant earnings miss
LONDON - Spreadex LTD, a UK-based financial trading company, has notified Ironveld PLC, a British issuer, of crossing the threshold of 4% total voting rights held in the company. The transaction took place on May 23, 2025, with Spreadex acquiring additional financial instruments that increased their total voting rights from 3.9579% to 4.0003%.
The notification, following the standard form TR-1 for major holdings, indicates that Spreadex now directly holds 2.5805% of the voting rights attached to shares and 1.4198% through financial instruments, specifically Contracts for Difference (CFDs) or Spread Bets. The total number of voting rights held by Spreadex in Ironveld PLC is 549,727,775.
Spreadex, founded in 1999, is regulated by the Financial Conduct Authority (FCA) and offers spread betting and CFD trading across more than 10,000 global markets, including UK small caps. The company has emphasized that it is not controlled by any natural person or legal entity and does not control any other undertakings with a notifiable interest in Ironveld PLC.
The completion of the notification form was carried out in the UK on May 23, 2025. This information is based on a press release statement and has been disseminated by RNS, the news service of the London Stock Exchange (LON:LSEG), which is authorized by the Financial Conduct Authority as a Primary Information Provider in the United Kingdom (TADAWUL:4280).
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.